Heron Therapeutics Inc vs Lithium Americas Corp — how do they compare? Heron Therapeutics Inc trades at $0.32 (market cap $61.47M), while Lithium Americas Corp trades at $3.27 (market cap $1.18B). The key difference: Lithium Americas Corp is far larger — about 19.2× Heron Therapeutics Inc's market cap. Which is the better fit depends on your goals.
| HRTX | LAC | |
|---|---|---|
Market Cap | $61.47M | $1.18B |
Sector | Health | Basic Materials |
52-Week High | $1.49 | $10.05 |
52-Week Low | $0.32 | $2.71 |
Enterprise Value | $168.21M | $1.29B |
Trailing returns across standard periods
Latest headlines on both assets
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →Lithium Americas is a resource company focused on developing the Thacker Pass project in Nevada, the largest known lithium resource in the US. It aims to become a major supplier for the electric vehicle battery market.
Read more on LAC →